| 靶点: |
IC50: 3.2 nM (11β-HSD1 enzymatic), 1.1 nM (11β-HSD1 PBMC) |
| 体内研究: |
INCB13739 (Orally) is effectively distributed in the adipose tissue and is inhibiting 11β-HSD1 activity > 90% for at least 24 h post-dose. INCB13739 (3 mg/kg, IV; 10 mg/kg, PO; once) displays decent oral bioavailability in both rats and cynomolgus monkeys.
Pharmacokinetic Parameters of INCB13739 in rats. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.139 ml |
10.695 ml |
21.389 ml |
| 5 mM |
0.428 ml |
2.139 ml |
4.278 ml |
| 10 mM |
0.214 ml |
1.069 ml |
2.139 ml |
| 50 mM |
0.043 ml |
0.214 ml |
0.428 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |